Literature DB >> 24733381

Establishment and maintenance of B cell identity.

Rudolf Grosschedl1.   

Abstract

B lymphocyte differentiation is dependent on an intricate interplay of transcription factors and signaling pathways to establish a lineage-specific program of gene expression. Functional perturbations of several transcription factors by gain- or loss-of-function experiments indicated that E2A, EBF1, and FoxO1 are required for the specification of the B cell lineage, whereas Pax5 antagonizes alternative cell fates by repressing genes that allow for responsiveness to T lymphoid- and myeloid-promoting signals. However, genome-wide analysis of EBF1-binding sites and their functional interrogation indicated that EBF1 is involved in both activation of the B cell program and repression of alternative cell fates. Recent studies indicate that EBF1 function is required throughout the B cell lineage until the onset of plasma cell differentiation and includes a role in the maintenance of B cell identity. Thus, early B cell differentiation requires intertwined networks of transcription factors in which EBF1 collaborates with E2A and FoxO1 to activate the B lineage program and acts together with Pax5 to antagonize alternative cell fates.
Copyright © 2013 Cold Spring Harbor Laboratory Press; all rights reserved.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24733381     DOI: 10.1101/sqb.2013.78.020057

Source DB:  PubMed          Journal:  Cold Spring Harb Symp Quant Biol        ISSN: 0091-7451


  8 in total

1.  Coactivation of NF-κB and Notch signaling is sufficient to induce B-cell transformation and enables B-myeloid conversion.

Authors:  Yan Xiu; Qianze Dong; Lin Fu; Aaron Bossler; Xiaobing Tang; Brendan Boyce; Nicholas Borcherding; Mariah Leidinger; José Luis Sardina; Hai-Hui Xue; Qingchang Li; Andrew Feldman; Iannis Aifantis; Francesco Boccalatte; Lili Wang; Meiling Jin; Joseph Khoury; Wei Wang; Shimin Hu; Youzhong Yuan; Endi Wang; Ji Yuan; Siegfried Janz; John Colgan; Hasem Habelhah; Thomas Waldschmidt; Markus Müschen; Adam Bagg; Benjamin Darbro; Chen Zhao
Journal:  Blood       Date:  2020-01-09       Impact factor: 22.113

2.  Role of Polycomb RYBP in Maintaining the B-1-to-B-2 B-Cell Lineage Switch in Adult Hematopoiesis.

Authors:  Carmela Calés; Leticia Pavón; Katarzyna Starowicz; Claudia Pérez; Mónica Bravo; Tomokatsu Ikawa; Haruhiko Koseki; Miguel Vidal
Journal:  Mol Cell Biol       Date:  2015-12-28       Impact factor: 4.272

3.  Bone marrow transcriptome and epigenome profiles of equine common variable immunodeficiency patients unveil block of B lymphocyte differentiation.

Authors:  Rebecca L Tallmadge; Lishuang Shen; Chia T Tseng; Steven C Miller; Jay Barry; M Julia B Felippe
Journal:  Clin Immunol       Date:  2015-05-16       Impact factor: 3.969

4.  Charting the cis-regulome of activated B cells by coupling structural and functional genomics.

Authors:  Virendra K Chaudhri; Krista Dienger-Stambaugh; Zhiguo Wu; Mahesh Shrestha; Harinder Singh
Journal:  Nat Immunol       Date:  2019-12-23       Impact factor: 25.606

5.  Repression of TCF3/E2A contributes to Hodgkin lymphomagenesis.

Authors:  Hanfeng Guan; Linka Xie; Thomas Wirth; Alexey Ushmorov
Journal:  Oncotarget       Date:  2016-06-14

Review 6.  ZNF423 and ZNF521: EBF1 Antagonists of Potential Relevance in B-Lymphoid Malignancies.

Authors:  Maria Mesuraca; Emanuela Chiarella; Stefania Scicchitano; Bruna Codispoti; Marco Giordano; Giovanna Nappo; Heather M Bond; Giovanni Morrone
Journal:  Biomed Res Int       Date:  2015-12-16       Impact factor: 3.411

7.  Pre-mitotic genome re-organisation bookends the B cell differentiation process.

Authors:  Wing Fuk Chan; Hannah D Coughlan; Gordon K Smyth; Timothy M Johanson; Rhys S Allan; Jie H S Zhou; Christine R Keenan; Naiara G Bediaga; Philip D Hodgkin
Journal:  Nat Commun       Date:  2021-02-26       Impact factor: 14.919

8.  Activation of Clustered IFNγ Target Genes Drives Cohesin-Controlled Transcriptional Memory.

Authors:  Wojciech Siwek; Sahar S H Tehrani; João F Mata; Lars E T Jansen
Journal:  Mol Cell       Date:  2020-10-26       Impact factor: 17.970

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.